Page 10 – Certara

Phoenix WinNonlin: A State of the Art Software Tool for Pre-clinical PK and TK Analysis

Are you currently using Excel for PK/TK analysis? Phoenix WinNonlin streamlines analyses and generates all of the output needed for non-compartmental analysis, TK, PK and PK/PD studies from within a single, validatable environment. Highlights of this webinar included: Sophisticated plotting of PK data Calculation of key PK parameters Cmax, Tmax, AUClast, AUCinf, Clearance Statistical summary […]

Speaker(s): Christopher Mehl

Solution: Model-informed Drug Development, PK/PD Modeling & Simulation

Introduction to Population PK/PD Analysis Using Phoenix NLME

Phoenix NLME provides sophisticated algorithms and powerful and flexible data processing and modeling tools for population PK/PD analyses with an intuitive graphical user interface. The Phoenix system can be customized for any type of modeler from beginners to experts. Phoenix NLME is easy to learn as it has built-in PK/PD libraries that can be used […]

Speaker(s): Serge Guzy

Solution: Model-informed Drug Development, PK/PD Modeling & Simulation

Powering Pediatric Studies to Meet FDA Criteria

Effective medications are a mainstay of modern pediatric medicine. Yet, ethical concerns about conducting clinical trials in pediatric patients are a major challenge in pediatric drug development. Learn how Dr. Samer Mouksassi and his team at Certara Strategic Consulting have overcome these challenges through the use of pharmacometrics.

Speaker(s): Samer Mouksassi

Solution: Clinical Trials Simulation, Model-informed Drug Development, PK/PD Modeling & Simulation

Therapeutic Area: Pediatrics

Refine Your Search

Solutions

Therapeutic Areas

Resource Type

Explore Our Scientific Resource Library

Phoenix WinNonlin: A State of the Art Software Tool for Pre-clinical PK and TK Analysis

Introduction to Population PK/PD Analysis Using Phoenix NLME

Powering Pediatric Studies to Meet FDA Criteria